World Immigration News

How Trump’s Immigration Policies Could Affect Biopharma Professionals’ Work Visas

Release Date: 2024-12-05
Media: BioSpace
Summary: Concerns are rising about the impact of President-elect Donald Trump's immigration policies on foreign-born biopharma professionals, particularly regarding the difficulty in obtaining work visas. Immigration attorneys Maria Kallmeyer and Sandra Feist highlighted that, based on Trump’s first administration, H-1B visas (for specialty occupations) are likely to be more affected than O-1 visas (for individuals with extraordinary abilities). Previous policies, such as travel bans and stricter visa extensions, have already created uncertainty.

Experts suggest that foreign-born biopharma professionals should plan ahead by applying for visa extensions early, maintaining records of their achievements, and starting the green card process soon. While these policies could make the process harder, Feist reassured that foreign-born professionals are unlikely to be directly targeted, although challenges will increase.
Tags: USA

Released on

Article Title